SLC35A2 and epilepsy: These range from systemic conditions such as congenital disorders of glycosylation (SLC35A2-CDG) to focal cortical malformations, most notably mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE).